Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL |
Temple University / Christian Hurtz, PhD |
'A' Award Grants |
2022 |
Pennsylvania |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
The Role of MST1 in Non-canonical Hippo Signaling in Rhabdomyosarcoma |
Duke University / Lisa Crose, Ph.D. |
'A' Award Grants |
2014 |
North Carolina |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML |
Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD |
'A' Award Grants |
2012 |
Washington |
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis |
Washington University / Jeffrey Magee, MD/PhD |
'A' Award Grants |
2016 |
Missouri |
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia |
Washington University / Grant Challen, PhD |
'A' Award Grants |
2012 |
Missouri |
Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting |
St. Jude Children’s Research Hospital / Stephen Mack, PhD |
'A' Award Grants |
2018 |
Tennessee |